Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard Benjamin is active.

Publication


Featured researches published by Richard Benjamin.


Journal of Autoimmunity | 1988

A Theoretical Framework for Self-tolerance and its Relevance to Therapy of Autoimmune Disease

Herman Waldmann; Steve Cobbold; Richard Benjamin; Shixin Qin

Abstract Therapeutic intervention in autoimmune diseases should be based on a knowledge of how the normal immune system maintains unresponsiveness to ‘self’ and how this state of unresponsiveness may be broken. We have proposed that ‘self’ from the viewpoint of T cells may represent only a small fraction of the peptides that are available in the body. These would be the peptides that successfully access MHC molecules on a limited number of antigen presenting cells. As the number of self peptides is far greater than that of useful MHC molecules, then the set that are privileged to access MHC on presenting cells will compete or buffer out the others. In other words the peptides which are immunologically visible establish tolerance to themselves whilst ensuring that many others remain cryptic. On this model, organ-specific autoimmunity is not a breakdown of tolerance but rather a failure to keep certain peptides from associating with MHC molecules on cells involved in antigen presentation. This could be at either the inductive side of the response or on the target side if mimicry by foreign antigens has primed the effector arm of the immune response. Monoclonal antibodies (MoAbs) have proved to be useful immuno-suppressive agents. MoAbs to certain T-cell adhesion molecules may also permit tolerance to occur to antigens administered simultaneously with them. The possibility of establishing tolerance to exposed peptides in autoimmunity is discussed. We propose that T cells whatever their stage of maturation can be tolerized as long as they see antigen in the absence of helpful stimuli from other cells.


Molecular Mechanisms of Immunological Self-Recognition | 1993

Tolerance Induction in the Peripheral Immune System

Matt Wise; Richard Benjamin; Shixin Qin; Stephen P. Cobbold; Herman Waldmann

Publisher Summary This chapter discusses the tolerance induction in the peripheral immune system. T-cell tolerance can be induced in mice to the foreign protein human gamma globulin (HGG) by giving that protein under the umbrella of CD4 mAb therapy. By choosing a rat CD4 mAb that cannot kill T cells in vivo , and by using adult thymectomized mice, it can be shown that any tolerance must be determined through the peripheral T-cell system alone. The chapter presents a study that showed that peripheral tolerance is antigen specific and functionally permanent. It arises and is maintained solely within the CD4 + T cell subpopulation, as CD8-depleted mice are equivalently tolerizable and maintain their state of tolerance indefinitely. The most remarkable feature of the model is that within tolerant animals, the CD4 compartment contains cells capable of resisting normal T cells from breaking that tolerant state, when these cells are transferred from a normal donor to the tolerant host. This suggests that the tolerant CD4 + T cells are not inert or nonfunctional but are capable of interacting to inhibit the function of non-tolerant cells.


Journal of Experimental Medicine | 1989

Induction of classical transplantation tolerance in the adult.

Shixin Qin; Stephen P. Cobbold; Richard Benjamin; Herman Waldmann


European Journal of Immunology | 1987

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

Shixin Qin; Steve Cobbold; Helen Tighe; Richard Benjamin; Herman Waldmann


European Journal of Immunology | 1988

Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination.

Richard Benjamin; Shixin Qin; Matt Wise; Stephen P. Cobbold; Herman Waldmann


Cold Spring Harbor Symposia on Quantitative Biology | 1989

Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1).

H. Waldmann; Stephen P. Cobbold; Shixin Qin; Richard Benjamin; Matthew Peter Wise


Progress in allergy | 1988

Monoclonal Antibodies for Immunosuppression

Herman Waldmann; Geoffrey Hale; Mike Clark; Steve Cobbold; Richard Benjamin; Peter F. Friend; Carole Bindon; Martin J. S. Dyer; Shixin Qin; Marianne Brüggemann; Helen Tighe


Archive | 1990

MONOCLONAL ANTIBODY THERAPY FOR THE PREVENTION OF GRAFT-VS.-HOST DISEASE

Herman Waldmann; G Hale; S. R. Cobbold; Michael Ronald Clark; Shixin Qin; Richard Benjamin; Martin J. S. Dyer


Ciba Foundation symposium | 1987

Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.

H. Waldmann; Stephen P. Cobbold; Shixin Qin; Richard Benjamin; Nash T; Welsh J; Tarnesby G


Ciba Foundation Symposium 129 - Autoimmunity and Autoimmune Disease | 2007

Monoclonal Antibodies for the Depletion of Specific Subpopulations of Lymphocytes

Herman Waldmann; Steve Cobbold; Shixin Qin; Richard Benjamin; Tony Nash; Jane Welsh; Georgia Tarnesby

Collaboration


Dive into the Richard Benjamin's collaboration.

Top Co-Authors

Avatar

Shixin Qin

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H. Waldmann

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar

Helen Tighe

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matt Wise

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge